ArticleNature genetics2026
MIXPRS enables multi-population and multi-method polygenic risk scores using summary statistics.
Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MIXPRS enables multi-population and multi-method polygenic risk scores using summary statistics.Nature genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Many multi-population polygenic risk score (PRS) methods have been proposed to improve prediction in underrepresented populations; however, no single method performs best across all scenarios. Although integrating PRSs across multiple methods and populations may improve prediction, this approach is often limited by the need for individual-level tuning data. Here we introduce MIXPRS, a robust framework based on the data fission paradigm for combining multiple multi-population PRS methods using only genome-wide association study summary statistics. MIXPRS uses single nucleotide polymorphism pruning to mitigate linkage disequilibrium mismatch and non-negative least squares regression to estimate combination weights. Across simulations and real-data analyses spanning up to 26 traits, MIXPRS consistently improves prediction accuracy over existing methods. We further extend this framework to MIXPRS+, incorporating functional annotations and clinical PRSs, yielding additional gains in non-European populations. MIXPRS relies only on summary statistics, thus offering broad accessibility and robustness for underrepresented populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.